MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy – a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis
Open Access
- 17 December 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 172 (1) , 239-247
Abstract
Purpose Pseudoprogression is an atypical imaging pattern of response to immunotherapy in patients with brain tumors. MR perfusion studies in this field are limited. The purpose of our study is to compare the perfusion features between pseudoprogression lesions in malignant gliomas and brain metastases treated with immunotherapy (iPsP) and the pseudoprogression after chemo-radiation therapy and radiation necrosis after radiation treatment (ChR-PsP & RN). Methods We retrospectively reviewed 25 iPsP lesions in 16 brain tumor patients and 48 ChR-PsP & RN lesions in 35 patients. The cerebral blood volume (CBV) of MR dynamic susceptibility contrast (DSC) perfusion weighted imaging (PWI) was analyzed, and the mean and maximal values of the ratio of CBV (rCBVmean and rCBVmax) of iPsPs and ChR-PsP & RNs were calculated and compared between these two groups using the Mann-Whitney U test. A receiver operating characteristic curve analysis was conducted, and the optimal cutoff of perfusion parameters were determined using the area under the curve, sensitivity, and specificity. Results The medians of rCBVmean and rCBVmax in iPsP group were significantly higher (0.94 and 1.39 respectively) than ChR-PsP & RN group (0.67, p < 0.01 and 1.1, p = 0.01 respectively). The rCBVmean value of 0.69 can differentiate the iPsP from ChR-PsP & RN with the area under the curve of 0.71, sensitivity of 0.72, and specificity of 0.56. Conclusion These findings may suggest immunotherapy-induced higher perfusion in the iPsP lesions compared to ChR-PsP & RN lesions in primary and metastatic brain tumors..Keywords
Funding Information
- This work was supported by Scientists in the Bureau of Science and Technology of ShaoGuan (230329238033088)
This publication has 32 references indexed in Scilit:
- Comparison of clinically available dynamic susceptibility contrast post processing software to differentiate progression from pseudoprogression in post-treatment high grade gliomaEuropean Journal of Radiology, 2023
- MR Perfusion Imaging for GliomasMagnetic Resonance Imaging Clinics of North America, 2023
- Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trialEuropean Radiology, 2020
- Pseudoprogression and Hyperprogression as New Forms of Response to ImmunotherapyBioDrugs, 2020
- Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: a comparison with relative CBVClinical Radiology, 2018
- Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical TrialsNeurotherapeutics, 2017
- Perfusion magnetic resonance imaging: Comparison of semiologic characteristics in first-pass perfusion of brain tumors at 1.5 and 3 TeslaJournal Of Neuroradiology, 2012
- Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modelingMagnetic Resonance Imaging, 2011
- MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot studyNeuroradiology, 2010
- Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgeryJournal of Neuro-Oncology, 2010